Young R. Shim1*, Rebecca Eaker1, Junkoo Park2
1Department of Psychology, Georgia Gwinnett College, Georgia, USA
2Department of Mathematics, Georgia Gwinnett College, Georgia, USA
Objective: The present study examined whether psychoeducational tools are beneficial in improving awareness and reducing stigma regarding mental health. This study aims to increase mental health awareness and reduce the stigma associated with mental illness.
Methods: The study is quantitative research. In this study, 147 students registered in the Abnormal Psychology course, which focuses on mental illness, were recruited. Students signed informed consent and participated in the study voluntarily. Students completed the demographic questions, Beliefs Toward Mental Illness Scale (BTMI), and Stig-9 questionnaire (stig-9).
Results: Our findings revealed a significant difference in beliefs and awareness about mental health and a decrease in stigma after students completed the Abnormal Psychology course. The statistical analysis revealed that students believe mental health is more curable and less embarrassing after taking mental health education. Finally, our findings demonstrated a direct impact of the educational experience on student attitudes toward mental health.
Conclusion: Our finding indicates that mental health education is a promising tool to raise awareness and understanding and reduce the stigma regarding mental health. Providing students with mental health education and training enabled students to learn and understand issues with mental illness. This study demonstrated a direct impact on the educational experience on student attitudes toward mental health.DOI: 10.29245/2578-2959/2022/2.1258 View / Download Pdf
Seyed-Shahab Banihashem1, Sahar Ashrafzadeh2, Mehrshad Poursaied Esfahani3, Zeinab Morsalivachin4, Alireza Shamsi5, Somaye Motazedian6, Mohammadreza Mousavipour7*
1Department of Psychosomatic Medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2David Geffen School of Medicine, University of California, Los Angeles, CA, USA
3Department of Sports and Exercise Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Department of Surgery School of Medicine, Iran University of Medical Sciences. Tehran, Iran
5Shahid Beheshti University of Medical Sciences, Taleghani Hospital
6Taleghani Hospital, Department of Psychosomatic Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Purpose: To compare the effects of lithium and valproate on the body composition of psychiatric patients.
Methods: This prospective cohort study evaluated the effects of lithium and valproate on body composition. Twenty-eight patients with type I bipolar disorder aged 23-54 years who just had started monotherapy were recruited. Body weight, percent body fat (PBF), soft lean mass, body mass index (BMI), and total body water were measured at baseline, one month, and six months. Changes in the body composition parameters between patients taking lithium (n=14) versus valproate (n=14) were compared.
Findings: Overall mean age of study participants was 37.21 (±8) years, and 53.5% of patients were female. Average body weight gains in the first month were 1.3 kg and 2.2 kg for the lithium and valproate groups, respectively (p-value = 0.042). Mean body weight gain in the six months compared to the baseline was only 0.6 kg for the lithium group, while it was 4.3 kg for the valproate group (p-value < 0.001). The average increase in PBF at six months among patients treated with lithium versus valproate was 0.07% versus 2.2% respectively (p-value = 0.018). Patients treated with lithium had a smaller increase in their BMI in the sixth month of the study compared to the valproate group, with a mean change of 0.2 versus 2.3 kg/m2, respectively (p-value = 0.019).
Conclusions: Our findings suggest that in patients with type I bipolar disorder, valproate leads to greater weight gain, BMI, and increase in PBF compared to lithium.DOI: 10.29245/2578-2959/2022/3.1255 View / Download Pdf
NYC Health + Hospitals/North Central Bronx, NY, USA
Healthcare systems have long recognized the impact of adverse health events on patients and families, and in recent years have gone further to identify the resulting emotional strains on the healthcare workforce. This attention to emotional health, which has been described as the overall state of one's emotions and the ability to manage and adapt to stressors, is also referred to as "emotional wellness" or "wellbeing." As this concept of wellness expands and evolves in the midst of the COVID-19 pandemic into a priority on the wellbeing of those in the helping professions, the current review explores the existing literature on the impact of compassion fatigue, compassion satisfaction, and their relationship to occupational burnout, with the conclusion that the emotional wellness of healthcare stakeholders and the health of an organization itself are not mutually exclusive. A review of these identified areas of occupational wellness is conducted, as well as a summary of findings emphasizing its significant implications for the healthcare workforce moving forward, both in relation to tangible costs to the healthcare industry and its reach to the bedside in the form of reported patient experience.DOI: 10.29245/2578-2959/2022/2.1150 View / Download Pdf
Comparison of Methamphetamine Induced Psychosis and Primary Psychotic Disorder: Scoping Review of Social Cognition
Felix Diotte1, Stephane Potvin2, Donna Lang3, Amal Abdel-Baki4, Alicia Spidel5, Marie Villeneuve6, Tania Lecomte1*
1Departement of psychology, University of Montréal
2Departement of psychiatry and addiction, University of Montréal, Canada,
3Department of Radiology, University of British Columbia, Canada,
4Centre hospitalier de l'Université de Montréal, Canada,
5University of Fraser Valley, Fraser Health, Canada,
6Institut universitaire en santé mentale de Montréal, Canada
As many as 43% of methamphetamine users will have a psychotic episode in their lifetime. Of these, 30% will develop a primary psychotic disorder, such as schizophrenia. The current state of the literature does not currently allow us to determine who will develop a primary psychotic disorder following a methamphetamine-induced psychosis (MIPD). This distinction is important, since people with a first episode of a psychotic disorder need specific and rapid treatments to ensure optimal recovery. Social cognition could help predict distinct profiles. The aim of this scoping review is to evaluate the literature in order to extract the differences between MIPD and primary psychotic disorders in the domain of social cognition. Articles were recovered from PsychINFO, Medline and Web of science and were retained if they met the following inclusion criteria: (a) original research or meta-analyses, (b) complete or partial sample with a psychotic disorder diagnosis with comorbid methamphetamine use, or MIPD, (c) studies focusing on the difference between a methamphetamine-induced psychosis and a primary psychotic disorder, and (d) studies focusing on social cognition in psychotic or methamphetamine using population. A total of 17 articles were identified, with none directly aiming at distinguishing MIPD and primary psychotic disorder using social cognition. Future studies on social cognition are needed in order to determine differences in the severity of deficits between the two profiles.DOI: 10.29245/2578-2959/2022/2.1144 View / Download Pdf